ラサギリン
“Clinical Pharmacology of Rasagiline: A Novel, Second-Generation Propargylamine for the Treatment of Parkinson Disease” (英語). The Journal of Clinical Pharmacology 45 (8): 878–894. doi:10.1177/0091270005277935. http://doi.wiley.com/10.1177/0091270005277935.
↑ “Binding of rasagiline-related inhibitors to human monoamine oxidases: a kinetic and crystallographic analysis”. Journal of Medicinal Chemistry 48 (26): 8148–54. (December 2005). doi:10.1021/jm0506266. PMC 2519603. PMID 16366596. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2519603/.
↑ “Rasagiline - a novel MAO B inhibitor in Parkinson's disease therapy”. Therapeutics and Clinical Risk Management 3 (3): 467–74. (June 2007). PMC 2386362. PMID 18488080.